11 unknown. 11 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 1 | 4 | Unknown 4 |
| Phase 3 | 1 | Unknown 1 |
Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MSP3-CRM-Vac4All/ Alhydrogel® Vaccine MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine - Malaria,Falciparum | Phase 1 / Phase 2 | Unknown | Vac4All | 465 | 2023-03-27 | 2023-04-26 |
| Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers Vaccine PvCS N+C+R 150 mcg, Placebo SSN Montanide ISA-51 1 mL - Malaria, Vivax | Phase 2 | Unknown | Malaria Vaccine and Drug Development Center | 120 | 2021-06-01 | 2021-03-01 |
| Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections Pyronaridine tetraphosphate 180mg:artesunate 60mg - Malaria,Falciparum | Phase 2 | Unknown | Shin Poong Pharmaceutical Co. Ltd. | 300 | 2018-10-03 | 2019-09-30 |
| Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites Imatinib, Dihydroartemisinin-piperaquine - Plasmodium Falciparum Malaria (Drug Resistant) | Phase 2 | Unknown | Nurex S.r.l. | 50 | 2017-09-17 | 2018-10-05 |
| Plasmodium Immunotherapy for Lung Cancer Blood-stage infection of P. vivax - Lung Cancer, Nonsmall Cell | Phase 1 / Phase 2 | Unknown | State Key Laboratory of Respiratory Disease | 30 | 2016-06-27 | 2023-06-22 |
| Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage) Lyophilised PEBS synthetic protein (PfPEBS), Rehydragel™ HPA - Malaria | Phase 1 / Phase 2 | Unknown | Vac4All | 36 | 2012-05-01 | 2012-05-25 |
| Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria Fosmidomycin and clindamycin - Malaria | Phase 2 | Unknown | Zentopharm GmbH | 100 | 2011-06-01 | 2011-05-26 |
| Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults Fosmidomycin, Azithromycin - Malaria | Phase 2 | Unknown | Jomaa Pharma GmbH | 43 | 2008-11-01 | 2011-11-03 |
| Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine MSP3 Long Synthetic Peptide 30 micrograms of MSP3 LSP, Verorab vaccine - Malaria | Phase 2 | Unknown | African Malaria Network Trust | 378 | 2008-05-01 | 2008-05-07 |
| Randomized Trial of Erythropoietin During Cerebral Malaria Placebo, Erythropoietin - Cerebral Malaria | Phase 2 / Phase 3 | Unknown | Claude Bernard University | 120 | 2007-10-01 | 2008-06-13 |
| IPTi in Mozambican Infants for Malaria Prevention Sulfadoxine-Pyrimethamine (Fansidar) - Malaria | Phase 1 / Phase 2 | Unknown | Hospital Clinic of Barcelona | 1498 | 2002-09-01 | 2006-11-16 |
Malaria, Falciparum (5) · Malaria, Vivax (2) · Carcinoma, Non-Small-Cell Lung (1) · Malaria, Cerebral (1)
Infections (11) · Mosquito-Borne Diseases (11) · Parasitic Diseases (11) · Protozoan Infections (11) · Vector Borne Diseases (11) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Parasitic Infections (1) · Central Nervous System Protozoal Infections (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1)
fosmidomycin (2) · Aluminum Hydroxide (1) · Artesunate (1) · Azithromycin (1) · Clindamycin (1) · Erythropoietin (1) · Imatinib Mesylate (1) · benzene-1,4-diphosphonic acid (1) · epoetin beta (1) · fanasil, pyrimethamine drug combination (1) · pyronaridine (1) · pyronaridine tetraphosphate, artesunate drug combination (1)
Vac4All (2) · African Malaria Network Trust (1) · Claude Bernard University (1) · Hospital Clinic of Barcelona (1) · Jomaa Pharma GmbH (1) · Malaria Vaccine and Drug Development Center (1) · Nurex S.r.l. (1) · Shin Poong Pharmaceutical Co. Ltd. (1) · State Key Laboratory of Respiratory Disease (1) · Zentopharm GmbH (1)
Mali (3) · China (1) · Colombia (1) · Gabon (1) · Mozambique (1) · Switzerland (1) · Thailand (1) · The Gambia (1) · Vietnam (1) · Zambia (1)
Clara Menendez, MD, PhD (1) · Francesco M Turrini, MD, PhD (1) · Francois Spertini, MD (1) · Huynh D Chien, MD, PhD (1) · Jang Sik Shin (1) · Mahamadou S Sissoko, MD, MSPH (1) · Manamadou Thera, MD (1) · Ming Ou-Yang, M.D. (1) · Pierre L Druilhe, MD (1) · Roma Chilengi, MBChB, MSc (1) · Saadou Issifou, MD PhD (1) · Srivicha Krudsood, Prof (1)
PMID 18419347, PMID 19630971, PMID 21292874, PMID 21931708, PMID 33983371